These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 32429317)

  • 1. Ellagic Acid Controls Cell Proliferation and Induces Apoptosis in Breast Cancer Cells via Inhibition of Cyclin-Dependent Kinase 6.
    Yousuf M; Shamsi A; Khan P; Shahbaaz M; AlAjmi MF; Hussain A; Hassan GM; Islam A; Rizwanul Haque QM; Hassan MI
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32429317
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of ellagic acid as an inhibitor of sphingosine kinase 1: A targeted approach towards anticancer therapy.
    Gupta P; Mohammad T; Khan P; Alajmi MF; Hussain A; Rehman MT; Hassan MI
    Biomed Pharmacother; 2019 Oct; 118():109245. PubMed ID: 31352240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting cyclin-dependent kinase 6 by vanillin inhibits proliferation of breast and lung cancer cells: Combined computational and biochemical studies.
    Yousuf M; Shamsi A; Queen A; Shahbaaz M; Khan P; Hussain A; Alajmi MF; Rizwanul Haque QM; Imtaiyaz Hassan M
    J Cell Biochem; 2021 Aug; 122(8):897-910. PubMed ID: 33829554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discovery of new small-molecule cyclin-dependent kinase 6 inhibitors through computational approaches.
    Luo X; Zhao Y; Tang P; Du X; Li F; Wang Q; Li R; He J
    Mol Divers; 2021 Feb; 25(1):367-382. PubMed ID: 32770459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Naringenin as a potential inhibitor of human cyclin-dependent kinase 6: Molecular and structural insights into anti-cancer therapeutics.
    Yousuf M; Shamsi A; Khan S; Khan P; Shahwan M; Elasbali AM; Haque QMR; Hassan MI
    Int J Biol Macromol; 2022 Jul; 213():944-954. PubMed ID: 35690164
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibiting CDK6 Activity by Quercetin Is an Attractive Strategy for Cancer Therapy.
    Yousuf M; Khan P; Shamsi A; Shahbaaz M; Hasan GM; Haque QMR; Christoffels A; Islam A; Hassan MI
    ACS Omega; 2020 Oct; 5(42):27480-27491. PubMed ID: 33134711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular dynamic behavior and binding affinity of flavonoid analogues to the cyclin dependent kinase 6/cyclin D complex.
    Khuntawee W; Rungrotmongkol T; Hannongbua S
    J Chem Inf Model; 2012 Jan; 52(1):76-83. PubMed ID: 22172011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elucidation of interaction mechanism of ellagic acid to the integrin linked kinase.
    Gulzar M; Syed SB; Khan FI; Khan P; Ali S; Hasan GM; Taneja P; Hassan MI
    Int J Biol Macromol; 2019 Feb; 122():1297-1304. PubMed ID: 30227205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reduced state transition barrier of CDK6 from open to closed state induced by Thr177 phosphorylation and its implication in binding modes of inhibitors.
    He H; Xu J; Xie W; Guo QL; Jiang FL; Liu Y
    Biochim Biophys Acta Gen Subj; 2018 Mar; 1862(3):501-512. PubMed ID: 29108955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ellagic acid, a phenolic compound, exerts anti-angiogenesis effects via VEGFR-2 signaling pathway in breast cancer.
    Wang N; Wang ZY; Mo SL; Loo TY; Wang DM; Luo HB; Yang DP; Chen YL; Shen JG; Chen JP
    Breast Cancer Res Treat; 2012 Aug; 134(3):943-55. PubMed ID: 22350787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring therapeutic potential of Rutin by investigating its cyclin-dependent kinase 6 inhibitory activity and binding affinity.
    Yousuf M; Khan S; Hussain A; Alajmi MF; Shamsi A; Haque QMR; Islam A; Hassan MI
    Int J Biol Macromol; 2024 Apr; 264(Pt 2):130624. PubMed ID: 38453105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ellagic acid inhibits human glioblastoma growth in vitro and in vivo.
    Wang D; Chen Q; Tan Y; Liu B; Liu C
    Oncol Rep; 2017 Feb; 37(2):1084-1092. PubMed ID: 28035411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C-glycosyl flavone from
    Bevara GB; Naveen Kumar AD; Koteshwaramma KL; Badana A; Kumari S; Malla RR
    Indian J Med Res; 2018 Feb; 147(2):158-168. PubMed ID: 29806604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of pteridin-7(8H)-one analogues as highly potent cyclin-dependent kinase 4/6 inhibitors: Synthesis, structure-activity relationship, and biological activity.
    Li Q; Chen L; Ma YF; Jian XE; Ji JH; You WW; Zhao PL
    Bioorg Chem; 2021 Nov; 116():105324. PubMed ID: 34509794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ellagic acid inhibits human pancreatic cancer growth in Balb c nude mice.
    Zhao M; Tang SN; Marsh JL; Shankar S; Srivastava RK
    Cancer Lett; 2013 Sep; 337(2):210-7. PubMed ID: 23684930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discovery and SARs of 5-Chloro-
    Wang Y; Chen X; Yan Y; Zhu X; Liu M; Liu X
    J Med Chem; 2020 Mar; 63(6):3327-3347. PubMed ID: 32129996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Search for Cyclin-Dependent Kinase 4/6 Inhibitors by Pharmacophore-Based Virtual Screening, Molecular Docking, and Molecular Dynamic Simulations.
    Susanti NMP; Damayanti S; Kartasasmita RE; Tjahjono DH
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibiting Cyclin-Dependent Kinase 6 by Taurine: Implications in Anticancer Therapeutics.
    Yousuf M; Shamsi A; Mohammad T; Azum N; Alfaifi SYM; Asiri AM; Mohamed Elasbali A; Islam A; Hassan MI; Haque QMR
    ACS Omega; 2022 Jul; 7(29):25844-25852. PubMed ID: 35910117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ellagic acid and human cancers: a systems pharmacology and docking study to identify principal hub genes and main mechanisms of action.
    Cheshomi H; Bahrami AR; Matin MM
    Mol Divers; 2021 Feb; 25(1):333-349. PubMed ID: 32410114
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unveiling Conformational States of CDK6 Caused by Binding of Vcyclin Protein and Inhibitor by Combining Gaussian Accelerated Molecular Dynamics and Deep Learning.
    Zhao L; Wang J; Yang W; Zhao K; Sun Q; Chen J
    Molecules; 2024 Jun; 29(11):. PubMed ID: 38893554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.